299
Halozyme Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
240
FY23:
389
FY24:
479
FY25:
652
Change from FY21 to FY25
millions USD
FY21:
−406
FY22:
−487
FY23:
−96.9
FY24:
−263
FY25:
−546
Change from FY21 to FY25
millions USD
FY21:
77.9
FY22:
362
FY23:
−408
FY24:
−219
FY25:
−85.2
millions USD
FY21:
−29.0
FY22:
115
FY23:
−116
FY24:
−2.52
FY25:
20.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
298
FY22:
235
FY23:
373
FY24:
468
FY25:
645
All amounts in millions USD